Related references
Note: Only part of the references are listed.Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates
Sakshi Mohan et al.
PLOS NEGLECTED TROPICAL DISEASES (2022)
Cutaneous and Mucocutaneous Leishmaniasis
I Abadias-Granado et al.
ACTAS DERMO-SIFILIOGRAFICAS (2021)
Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital
Marta Garrido-Jareno et al.
PARASITES & VECTORS (2020)
Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression
Pau Bosch-Nicolau et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Anti-tumour necrosis factor-associated cutaneous leishmaniasis: a single-institution experience
A. Martinez-Domenech et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Case Report: Diffuse Cutaneous Leishmaniasis by Leishmania infantum in a Patient Undergoing Immunosuppressive Therapy: Risk Status in an Endemic Mediterranean Area
M. Magdalena Alcover et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
Anti-Tumor Necrosis Factor a Therapeutics Differentially Affect Leishmania Infection of Human Macrophages
Katharina Arens et al.
FRONTIERS IN IMMUNOLOGY (2018)
A systematic review and meta-analysis of the prevalence of Leishmania infection in blood donors
Masoud Foroutan et al.
TRANSFUSION AND APHERESIS SCIENCE (2017)
Phlebotomine sand fly-borne pathogens in the Mediterranean Basin: Human leishmaniasis and phlebovirus infections
Martina Moriconi et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
The Equivocal Role of Th17 Cells and Neutrophils on Immunopathogenesis of Leishmaniasis
Suenia da C. Goncalves-de-Albuquerque et al.
FRONTIERS IN IMMUNOLOGY (2017)
Cutaneous leishmaniasis associated with anti-tumour necrosis factor-α drugs: an emerging disease
J. Marcoval et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2017)
Anti-Tumour Necrosis Factor-Induced Visceral and Cutaneous Leishmaniasis: Case Report and Review of the Literature
Alba Catala et al.
DERMATOLOGY (2015)
Cutaneous and mucocutaneous leishmaniasis Clinical perspectives
Marc Z. Handler et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Visceral leishmaniasis with cutaneous symptoms in a patient treated with infliximab followed by fatal consequences
Katerina Juzlova et al.
DERMATOLOGIC THERAPY (2014)
Cutaneous leishmaniasis in a patient receiving infliximab for psoriatic arthritis: treatment with cryotherapy and intralesional meglumine antimonate
A. Catala et al.
ACTAS DERMO-SIFILIOGRAFICAS (2014)
Visceral leishmaniasis in a patient taking adalimumab for rheumatoid arthritis
Catherine E. Berry et al.
MEDICAL JOURNAL OF AUSTRALIA (2013)
Imported case of visceral leishmaniasis presenting as pancytopenia in a Norwegian patient treated with methotrexate and etanercept for psoriasis arthritis
Emilio Besada et al.
RHEUMATOLOGY INTERNATIONAL (2013)
Cutaneous leishmaniasis in a patient receiving infliximab
Alicia Hernandez-Torres et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2013)
Clinical aspects and management of cutaneous leishnnaniasis in rheumatoid patients treated with TNF-α antagonists
Andreas L. C. Neumayr et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2013)
Persistent inflammation of the nasal dorsum in a patient with rheumatoid arthritis treated with infliximab
Jose Miguel Garcia-Castro et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2012)
Mucocutaneous leishmaniasis in a patient treated with anti-TNF-α therapy
Estrella Garcia-Gonzalez et al.
RHEUMATOLOGY (2012)
Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human
Gregory Michel et al.
ACTA TROPICA (2011)
Cutaneous Leishmaniasis With Pseudoepitheliomatous Hyperplasia Simulating Squamous Cell Carcinoma
Leonardo Pereira Quintella et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2011)
Pseudoepitheliomatous Hyperplasia: A Review
Maya Zayour et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2011)
Localized Cutaneous Leishmaniasis due to Leishmania infantum in a Patient Treated with Infliximab
S. Hakimi et al.
DERMATOLOGY (2010)
Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab: A case description and literature review
Diego Moreno et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2010)
An Atypical Presentation of Visceral Leishmaniasis Infection in a Patient With Rheumatoid Arthritis Treated With Infliximab
Konstantinos Kritikos et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2010)
Visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with adalimumab
Anna Molto et al.
JOINT BONE SPINE (2010)
Pseudolymphomatoid Cutaneous Leishmaniasis in a Patient Treated with Adalimumab for Rheumatoid Arthritis
Susana Balta-Cruz et al.
ACTA DERMATO-VENEREOLOGICA (2009)
Case Report: Relapsing Cutaneous Leishmaniasis in a Patient with Ankylosing Spondylitis Treated with Infliximab
Matthias C. Mueller et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2009)
Multifocal cutaneous leishmaniasis due to Leishmania infantum under adalimumab therapy
P. Schneider et al.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2009)
Pseudotumoral-like recurrence of visceral leishmaniasis in a seven-year-old girl
E. Jeziorski et al.
ARCHIVES DE PEDIATRIE (2009)
Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention
C. Garcia-Vidal et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2009)
Leishmaniasis, Autoimmune Rheumatic Disease, and Anti-Tumor Necrosis Factor Therapy, Europe
Ioannis D. Xynos et al.
EMERGING INFECTIOUS DISEASES (2009)
Asymptomatic infection by Leishmania infantum in blood donors from the Balearic Islands (Spain)
Cristina Riera et al.
TRANSFUSION (2008)
Visceral leishmaniasis in a patient with psoriatic arthritis treated with infliximab: reactivation of a latent infection?
Maria G. Tektonidou et al.
CLINICAL RHEUMATOLOGY (2008)
Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept
V. Bagalas et al.
CLINICAL RHEUMATOLOGY (2007)
Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab
M. Bassetti et al.
RHEUMATOLOGY (2006)
Visceral leishmaniasis related to infliximab administration
V Romaní-Costa et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2004)
The role of IL-12 in maintaining resistance to Leishmania major
AY Park et al.
JOURNAL OF IMMUNOLOGY (2002)
Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment
HW Murray et al.
INFECTION AND IMMUNITY (2000)
Share Paper
